Honjo, Japan

Kazuhiro Numata

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Kotai Kasei Co., Ltd., Taiho Pharmaceutical Company Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Numata. Retrieved from https://idiyas.com/inventor/kazuhiro-numata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiro Numata: Innovator in Sulfated Polysaccharides

Introduction

Kazuhiro Numata is a notable inventor based in Honjo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on sulfated polysaccharides.

Latest Patents

Kazuhiro Numata holds a patent for a sulfated polysaccharide and its pharmaceutically acceptable salt. This invention provides a sulfated polysaccharide (D-HG) that serves as an effective component for treating disseminated intravascular coagulation (DIC) and thrombosis. The sulfated polysaccharide is prepared by depolymerization of FGAG, a sulfated polysaccharide extracted from the body wall of a sea cucumber, which exhibits activities similar to those of heparin.

Career Highlights

Throughout his career, Kazuhiro Numata has worked with prominent companies in the pharmaceutical industry, including Taiho Pharmaceutical Company Limited and Kotai Kasei Co., Ltd. His expertise in the field has led to advancements in medical treatments and drug formulations.

Collaborations

Kazuhiro Numata has collaborated with notable colleagues, including Hui-Zeng Fan and Song Yu. Their combined efforts have contributed to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Kazuhiro Numata's work in sulfated polysaccharides has paved the way for new therapeutic options in treating serious medical conditions. His contributions to the field highlight the importance of innovation in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…